The goal of osteoporosis management is to prevent fractures. Several pharmacological
agents are available to lower fracture risk, either by reducing bone resorption or by …

Osteoporosis in men is a common but often overlooked disorder by clinicians. The criterion
for osteoporosis diagnosis in men is similar to that in women—namely, a bone mineral …

Osteoporosis care has evolved markedly over the last 50 years, such that there are now an
established clinical definition, validated methods of fracture risk assessment and a range of …

Objectives Inflammatory rheumatic and musculoskeletal diseases (iRMDs) are associated
with increased systemic bone loss that is mediated by chronic inflammation, treatment with …

Oral bisphosphonates are a key intervention in the treatment of osteoporosis and in
reducing the risk of fragility fractures. Their use is supported by over 3 decades of evidence; …

Background Osteoporosis is often considered to be a disease of women. Over the last few
years, owing to the increasing clinical and economic burden, the awareness and imperative …

Introduction The objective of this systematic review and meta-analysis is to systematically
identify and review the efficacy of pharmacological treatments in men with osteoporosis …

Rationale and Objectives Osteoporosis is primarily diagnosed using dual-energy X-ray
absorptiometry (DXA); yet, DXA is significantly underutilized, causing osteoporosis, an …

Historically, osteoporosis has been viewed as a disease of women, with research, trials of
interventions and guidelines predominantly focused as such. It is apparent, however, that …

To make the diagnosis of hypogonadism in an ageing man, in absence of rare organic
cause often referred to as functional or late onset hypogonadism (LOH), he should present …